These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31895759)

  • 1. The success rate of radioactive iodine therapy for Graves' disease in iodine-replete area and affecting factors: a single-center study.
    Park H; Kim HI; Park J; Park SY; Kim TH; Chung JH; Choi JY; Kim SW
    Nucl Med Commun; 2020 Mar; 41(3):212-218. PubMed ID: 31895759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease.
    Kim J; Choi MS; Park J; Park H; Jang HW; Choe JH; Kim JH; Kim JS; Cho YS; Choi JY; Kim TH; Chung JH; Kim SW
    Thyroid; 2021 Aug; 31(8):1264-1271. PubMed ID: 33947272
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
    Kaplowitz PB; Jiang J; Vaidyanathan P
    J Pediatr Endocrinol Metab; 2020 Mar; 33(3):383-389. PubMed ID: 31603857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors influencing the success rate of radioiodine treatment for Graves' disease.
    He M; Pan L; Li Y; Wang Y; Zhong X; Du Y; Pan T
    Diabetes Obes Metab; 2024 Oct; 26(10):4397-4409. PubMed ID: 39021354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Thyroid Stimulating Receptor Antibody Titre and Large Goitre Size at First-Time Radioactive Iodine Treatment are Associated with Treatment Failure in Graves' Disease.
    Tay WL; Chng CL; Tien CS; Loke KS; Lam WW; Fook-Chong SM; Tong AK
    Ann Acad Med Singap; 2019 Jun; 48(6):181-187. PubMed ID: 31377762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves' Disease.
    Kim MJ; Cho SW; Kim YA; Choi HS; Park YJ; Park DJ; Cho BY
    Endocrinol Metab (Seoul); 2022 Jun; 37(3):524-532. PubMed ID: 35709827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
    Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for higher success rates and successful treatment earlier in Graves' disease with higher radioactive iodine doses.
    Sztal-Mazer S; Nakatani VY; Bortolini LG; Boguszewski CL; Graf H; de Carvalho GA
    Thyroid; 2012 Oct; 22(10):991-5. PubMed ID: 22953990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between thyroid volume and humoral thyroid autoimmunity after radioiodine therapy in Graves' disease.
    Sawicka N; Sowiński J
    Endokrynol Pol; 2012; 63(1):10-3. PubMed ID: 22378091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
    Brito JP; Payne S; Singh Ospina N; Rodriguez-Gutierrez R; Maraka S; Sangaralingham LR; Iñiguez-Ariza NM; Montori VM; Stan MN
    Thyroid; 2020 Mar; 30(3):357-364. PubMed ID: 31973681
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term outcome and prognostic factors of single-dose Radioiodine Therapy in patients with Graves' disease.
    Yang YT; Chen JF; Tung SC; Kuo MC; Weng SW; Chou CK; Shen FC; Chang CM; Tsai CJ; Taso CF; Wang PW
    J Formos Med Assoc; 2020 May; 119(5):925-932. PubMed ID: 32057544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Patterns and Preferences for Graves' Disease in Korea: Insights from a Nationwide Cohort Study.
    Kim KJ; Choi J; Shin SM; Kim JA; Kim KJ; Kim SG
    Endocrinol Metab (Seoul); 2024 Aug; 39(4):659-663. PubMed ID: 39099390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cold iodine in patients with Graves' disease: observations from a clinical practice.
    Hao ST; Reasner CA; Becker RA
    Endocr Pract; 2001; 7(6):438-42. PubMed ID: 11747279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and Safety of Radioactive Iodine Therapy in Childhood Graves’ Disease in Khon Kaen, Thailand.
    Getsuwan S; Wiromrat P; Panamonta O; Panamonta M; Paireepinas S
    J Med Assoc Thai; 2016 Aug; 99 Suppl 5():S112-9. PubMed ID: 29905996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves' disease.
    Cohen RZ; Felner EI; Heiss KF; Wyly JB; Muir AB
    J Pediatr Endocrinol Metab; 2016 Mar; 29(3):319-25. PubMed ID: 26656610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioactive Iodine Therapy of Graves' Disease in Patients Pretreated With Methimazole Without Radioiodine Uptake for Dose Estimation.
    Mihailescu DV; Hoscheit C; Fogelfeld L
    Endocr Pract; 2024 Apr; 30(4):333-339. PubMed ID: 38307459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The occurrence of hypothyroidism following radioactive iodine treatment of toxic nodular goiter is related to the TSH level.
    Adamali HI; Gibney J; O'Shea D; Casey M; McKenna TJ
    Ir J Med Sci; 2007 Sep; 176(3):199-203. PubMed ID: 17632747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.